The Patent Finder

Cefo Co., Ltd.

7 patents currently held · Updated Nov 21, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Mar 2033
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Apr 30, 2027
    The maintenance fee for Culture Vessel for Three-Dimensional Cell Cultivation and Three-Dimensional Cell Co-Cultivation Method Using Same (US 11,802,263) comes due Apr 30, 2027. Unpaid by Nov 1, 2027, it lapses early.
  • 1 fee due Jun 3, 2027
    The maintenance fee for Method for inducing three-dimensional osteogenic differentiation of stem cells using hydrogel (US 10,494,601) comes due Jun 3, 2027. Unpaid by Dec 3, 2027, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 7 of 7

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 10,104,881Composition Comprising Plant-Derived Recombinant Human Serum Albumin, Lipids, and Plant Protein Hydrolysates as Active Ingredients for Cryopreservation of Stem Cells or Primary Cells
In force
 · High confidence
In forceHigh confidence
US 10,494,601Method for inducing three-dimensional osteogenic differentiation of stem cells using hydrogel
In force
 · USPTO record
In forceUSPTO record
US 10,752,880Three-dimensional cell culture system and cell culture method using same
In force
 · USPTO record
In forceUSPTO record
US 11,345,887Composition for Preserving Cells, Containing, as Active Ingredients, Plantderived Recombinant Human Serum Albumin and Plant Peptides
In force
 · High confidence
In forceHigh confidence
US 11,802,263Culture Vessel for Three-Dimensional Cell Cultivation and Three-Dimensional Cell Co-Cultivation Method Using Same
In force
 · High confidence
In forceHigh confidence
US 11,634,675Insertable Culture Container and Kit for Three-Dimensional Cell Culture, and Three-Dimensional Cell Co-Culture Method Using Same
In force
 · High confidence
In forceHigh confidence
US 12,702,130Cell Cryopreservation Device
In force
 · High confidence
In forceHigh confidence

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

1 pending · 1 abandoned · 1 no status recorded

Showing 1 to 3 of 3, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.

ApplicationTitleFiledStatus
17/918,093Osteoblasts Differentiated from Mesenchymal Stem Cells and Composition for Treating Bone Disease Comprising SameOct 8, 2021Pending
18/029,239Composition Including PLGF for Prevention or Treatment of Neuropsychologic DiseaseSep 29, 2021Abandoned
18/029,234Sep 29, 2021No status recorded
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited